Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Chernajovsky

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Systemic gene therapy for arthritisY Chernajovsky
FEBS Letters|December 4, 1989
Constitutive in vitro binding of nuclear proteins to the 5'-flanking region of 6-16, a human gene inducible by alpha, beta-interferonsY Chernajovsky
Rheumatology (Oxford, England)|October 9, 1999
Gene transfer as therapy for rheumatoid arthritis: why, what and how?Y Chernajovsky
Cancer Metastasis Reviews|July 1, 1990
Transformation injury and the unicellular phenotype of malignant cellsP Frost, Y Chernajovsky
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000
Recent developments in retroviral-mediated gene transductionG Daly, Y Chernajovsky
Gene Therapy|May 9, 2000
Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zetaA Annenkov, Y Chernajovsky
Gene Therapy|May 7, 2003
Targeting 'horror autotoxicus' by gene therapy: results, challenges and the futureL Layward, Y Chernajovsky
Handbook of Experimental Pharmacology|December 12, 2007
Historical development of monoclonal antibody therapeuticsA Nissim, Y Chernajovsky
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 1998
Mutation of proline 211 reduces shedding of the human p75 TNF receptorC Herman, Y Chernajovsky
Journal of Interferon Research|December 1, 1990
Regulation of the human interferon-inducible 6-16 promoter in tumor necrosis factor-sensitive and resistant mouse cells: role of cAMP as a mediator of signal transductionY Chernajovsky, T R Reid
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Systemic gene therapy for arthritisY Chernajovsky
FEBS Letters|December 4, 1989
Constitutive in vitro binding of nuclear proteins to the 5'-flanking region of 6-16, a human gene inducible by alpha, beta-interferonsY Chernajovsky
Rheumatology (Oxford, England)|October 9, 1999
Gene transfer as therapy for rheumatoid arthritis: why, what and how?Y Chernajovsky
Cancer Metastasis Reviews|July 1, 1990
Transformation injury and the unicellular phenotype of malignant cellsP Frost, Y Chernajovsky
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000
Recent developments in retroviral-mediated gene transductionG Daly, Y Chernajovsky
Gene Therapy|May 9, 2000
Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zetaA Annenkov, Y Chernajovsky
Gene Therapy|May 7, 2003
Targeting 'horror autotoxicus' by gene therapy: results, challenges and the futureL Layward, Y Chernajovsky
Handbook of Experimental Pharmacology|December 12, 2007
Historical development of monoclonal antibody therapeuticsA Nissim, Y Chernajovsky
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 1998
Mutation of proline 211 reduces shedding of the human p75 TNF receptorC Herman, Y Chernajovsky
Journal of Interferon Research|December 1, 1990
Regulation of the human interferon-inducible 6-16 promoter in tumor necrosis factor-sensitive and resistant mouse cells: role of cAMP as a mediator of signal transductionY Chernajovsky, T R Reid
Pageof 9